ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,821Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 761

$514K Total Retail Price of All Prescriptions

Rank: 118 out of 761

502 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,374 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
ATORVASTATIN CALCIUM 392 369 1 12
LISINOPRIL 339 302 2 1
AMLODIPINE BESYLATE 310 265 3 6
SIMVASTATIN 307 267 4 2
ATENOLOL 286 254 5 8
LEVOTHYROXINE SODIUM 259 221 6 3
FUROSEMIDE 244 229 7 7
WARFARIN SODIUM 241 236 8 9
HYDROCODONE-ACETAMINOPHEN 198 129 S3 9 5
OMEPRAZOLE 164 111 10 4
ZOLPIDEM TARTRATE 158 141 11 22
POTASSIUM CHLORIDE 154 141 12 18
HYDROCHLOROTHIAZIDE 148 138 13 11
LOSARTAN POTASSIUM 139 127 14 13
TRIAMTERENE-HCTZ 132 124 15 42
METFORMIN HCL 123 92 16 10
GABAPENTIN 118 87 17 15
METOPROLOL SUCCINATE 104 104 18 16
SERTRALINE HCL 91 53 19 25
METOPROLOL TARTRATE 91 87 19 14
TRAZODONE HCL 87 63 21 23
LOVASTATIN 79 50 22 17
ALENDRONATE SODIUM 75 75 23 21
TAMSULOSIN HCL 73 72 24 27
PRAVASTATIN SODIUM 72 70 25 20
FELODIPINE ER 71 64 26 108
ADVAIR DISKUS 69 58 27 37
LANTUS 67 49 28 41
CLOPIDOGREL 66 58 29 66
OXYCODONE HCL 65 62 S2 30 24
CARVEDILOL 64 39 31 26
ENALAPRIL MALEATE 61 57 32 71
CYCLOBENZAPRINE HCL 61 18 R 32 51
KLOR-CON 10 58 53 34 74
ALLOPURINOL 57 57 35 28
HYDRALAZINE HCL 57 57 35 114
TRAMADOL HCL 55 53 37 34
DOXAZOSIN MESYLATE 54 54 38 55
ZETIA 54 54 38 87
TRIAMTERENE-HYDROCHLOROTHIAZID 53 43 40 68
SPIRONOLACTONE 52 41 41 45
VERAPAMIL ER 52 42 41 109
CITALOPRAM HBR 51 30 43 19
CRESTOR 50 44 44 36
OXYBUTYNIN CHLORIDE 50 35 44 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.